RMD
$235.29 · +0.1% today · +4.1% 5d · +16.4% 3m · −12.9% 1y
Daily score48
Weekly score42
Long-term score53
Close
Scores (0–100)
Components — latest (2026-10-14)
Close
235.29
1D return
+0.1%
5D return
+4.1%
Rel volume
0.90
CMF 20
-0.14
OBV slope 20
0.12
Up-vol ratio 10
0.80
Short ratio
0.63
Short ratio Δ
+3.3%
Persistence 10
0.00
Inflow mean 5d
-0.09
Inflow mean 60d
0.23
Momentum 12-1
−15.1%
% of 52w high
+86.0%
vs 200d
+5.0%
Volatility 60d
+29.1%
Dollar vol 20d
$255.42M
Insider buys 90d
$0
Insider buyers 90d
0.00
Revenue growth
—
Fundamentals — ResMed · Health Care
as of 2026-10-22- P/E
- 26.1
- P/B
- 5.54
- ROE
- 21.3%
- Operating margin
- 32.7%
- Debt / equity
- 0.06
- FCF yield
- 4.6%
- Years profitable
- 5/5
- BM score
- 85
- Moat flag
- Yes
Insider trades (Form 4)
| Filed | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-10-08 | Farrell Michael J. | Chairman and CEO | Sell | 5.0K | $226.33 | $1.13M |
| 2026-09-10 | Farrell Michael J. | Chairman and CEO | Sell | 5.0K | $222.44 | $1.11M |
| 2026-09-04 | FARRELL PETER C | Director | Sell | 970 | $234.73 | $227.7K |
| 2026-08-11 | Farrell Michael J. | Chairman and CEO | Sell | 5.0K | $205.69 | $1.03M |
| 2026-08-06 | FARRELL PETER C | Director | Sell | 8.0K | $225.00 | $1.80M |
| 2026-07-09 | Farrell Michael J. | Chairman and CEO | Sell | 5.0K | $218.55 | $1.09M |
| 2026-06-09 | Farrell Michael J. | Chairman and CEO | Sell | 5.0K | $193.96 | $968.1K |
| 2026-05-11 | Farrell Michael J. | Chairman and CEO | Sell | 5.0K | $207.82 | $1.04M |
Congress trades
No congressional trades on file for RMD.